Fire & Flower Holdings Corp (FFLWF)
0.12
0.00 (0.00%)
USD |
OTCM |
Jun 07, 16:00
Fire & Flower Holdings Total Liabilities (Quarterly): 65.50M for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 65.50M |
| October 31, 2022 | 67.86M |
| July 31, 2022 | 61.47M |
| April 30, 2022 | 63.07M |
| January 31, 2022 | 84.00M |
| October 31, 2021 | 77.01M |
| July 31, 2021 | 86.64M |
| April 30, 2021 | 109.91M |
| January 31, 2021 | 139.02M |
| October 31, 2020 | 113.29M |
| Date | Value |
|---|---|
| July 31, 2020 | 90.21M |
| April 30, 2020 | 84.07M |
| January 31, 2020 | 78.77M |
| October 31, 2019 | 89.75M |
| July 31, 2019 | 75.42M |
| April 30, 2019 | 50.15M |
| November 30, 2018 | 0.0233M |
| August 31, 2018 | 0.0138M |
| May 31, 2018 | 0.0217M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
61.47M
Minimum
Jul 2022
139.02M
Maximum
Jan 2021
85.73M
Average
84.00M
Median
Jan 2022
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| InMed Pharmaceuticals Inc | 2.254M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.70M |
| Shareholders Equity (Quarterly) | 43.20M |
| Debt to Equity Ratio | 0.2381 |
| Current Ratio | 0.748 |
| Net Debt Paydown Yield | -4.96% |